Alcon introduces new Ciloxan formulation

Ciloxan is now available as an eye ointment containing ciprofloxacin 0.3% for the treatment of corneal ulcers, conjunctivitis and blepharitis.

Ciloxan eye ointment, containing 0.3% ciprofloxacin, is indicated for the treatment of corneal ulcers, conjunctivitis and blepharitis.

To treat corneal ulcers, 1.25 cm ointment should be applied into the conjunctival sac every 1 to 2 hours for 2 days, then every 4 hours for a further 12 days.

In conjunctivitis and blepharitis the ointment is applied, into the conjunctival sac or on the lid margin, respectively, three times daily for 2 days, then twice daily for a further 5 days.

In all indications the duration of treatment may be extended if considered necessary.

Ciloxan eye ointment is presented in 3.5 g tubes and has a basic NHS price of £5.49.

Ciloxan eye drops remain available.

View Ciloxan drug record

Further Information: Alcon Laboratories UK Ltd

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New once-weekly GLP-1 agonist for diabetes

New once-weekly GLP-1 agonist for diabetes

Ozempic (semaglutide) is a glucagon-like peptide-1...

Gluten-free prescribing restricted to bread and mixes

Gluten-free prescribing restricted to bread and mixes

GPs in England are no longer able to prescribe gluten-free...

New vitamin D deficiency thresholds recommended

New vitamin D deficiency thresholds recommended

The National Osteoporosis Society (NOS) has updated...

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors may be linked to a doubling in the...